Pure Global
NCT05965297

Comparison of Two GIC's in the Restoration of Posterior Class II Lesions in the Primary Dentition

Comparison of Two Conventional Glass Ionomer Cements in the Restoration of Posterior Class II Lesion in the Primary Dentition: a Randomized Controlled Non Inferiority Trial
DMG Dental Material Gesellschaft mbH·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Dental Caries
Drug/Device/Intervention
DeltaFil
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
DMG Dental Material Gesellschaft mbH
Location
Petrópolis,Coimbra, Brazil,Portugal
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Aug 01, 2030
Enrollment
140 participants
Primary outcome

Survival rate of Class II restorations

Summary

This study will investigate the clinical performance of a novel restorative glass ionomer
 (DeltaFil, DMG) in comparison to an established restorative glass ionomer (Riva Self Cure HV,
 SDI) in the restoration of Class II cavities in primary molars.

ICD-10 classifications
Dental cariesOther dental cariesDental caries, unspecifiedCaries of dentineCaries limited to enamel
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05965297
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05965297 through Pure Global AI's free database. This phase not specified trial is sponsored by DMG Dental Material Gesellschaft mbH and is currently Not yet recruiting. The study focuses on Dental Caries. Target enrollment is 140 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.